These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1805875)

  • 1. [Particulate contamination of amino acid solutions for parenteral use].
    Ferrari F; Bonferoni MC; Zamella C; La Manna A; Verrengio B; Pedroni M; Omodei-Sale A
    Boll Chim Farm; 1991 Nov; 130(10):402-8. PubMed ID: 1805875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid stability and microbial growth in total parenteral nutrient solutions.
    Parr MD; Bertch KE; Rapp RP
    Am J Hosp Pharm; 1985 Dec; 42(12):2688-91. PubMed ID: 3936355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of ceftazidime and amino acids in parenteral nutrient solutions.
    Wade CS; Lampasona V; Mullins RE; Parks RB
    Am J Hosp Pharm; 1991 Jul; 48(7):1515-9. PubMed ID: 1909093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential hazard of particulate contamination of cardioplegic solutions.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jan; 87(1):48-58. PubMed ID: 6690859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate contamination in New Zealand intravenous solutions.
    Passl WJ; Waring JM
    N Z Med J; 1980 Mar; 91(655):177-9. PubMed ID: 6929987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and chemical stability of pemetrexed in infusion solutions.
    Zhang Y; Trissel LA
    Ann Pharmacother; 2006 Jun; 40(6):1082-5. PubMed ID: 16720706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
    Johnson CE; Jacobson PA; Chan E
    Am J Hosp Pharm; 1994 Feb; 51(4):503-8. PubMed ID: 8017417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of aminophylline injection in three parenteral nutrient solutions.
    Niemiec PW; Vanderveen TW; Hohenwarter MW; Gadsden RH
    Am J Hosp Pharm; 1983 Mar; 40(3):428-32. PubMed ID: 6405614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of midazolam hydrochloride in parenteral nutrient solutions.
    Bhatt-Mehta V; Rosen DA; King RS; Maksym CJ
    Am J Hosp Pharm; 1993 Feb; 50(2):285-8. PubMed ID: 8480785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions.
    Bullock L; Parks RB; Lampasona V; Mullins RE
    Am J Hosp Pharm; 1985 Dec; 42(12):2683-7. PubMed ID: 3936354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of famotidine 20 and 40 mg/L and amino acids in total parenteral nutrient solutions.
    Bullock L; Fitzgerald JF; Glick MR; Parks RB; Schnabel JG; Hancock BG
    Am J Hosp Pharm; 1989 Nov; 46(11):2321-5. PubMed ID: 2511752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cysteine stability in aqueous amino acid solutions].
    Nekliudov AD; Verem'ëv IV
    Prikl Biokhim Mikrobiol; 1984; 20(3):387-92. PubMed ID: 6431404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiamine destruction by sodium bisulfite in infusion solutions.
    Scheiner JM; Araujo MM; DeRitter E
    Am J Hosp Pharm; 1981 Dec; 38(12):1911-3. PubMed ID: 7325171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-control plan for intravenous admixture programs. I: Visual inspection of solutions and environmental testing.
    Morris BG; Avis KE
    Am J Hosp Pharm; 1980 Feb; 37(2):189-95. PubMed ID: 7361790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stability of amino acid infusion solutions. 2. Stability of amino acid mixtures in solution].
    Seydel H; Voigt R
    Pharmazie; 1972 Jul; 27(7):460-6. PubMed ID: 5087243
    [No Abstract]   [Full Text] [Related]  

  • 19. Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions.
    Lee YC; Baaske DM; Amann AH; Carter JE; Mooers MA; Wagenknecht DM; Lai CM
    Am J Hosp Pharm; 1980 Jun; 37(6):803-8. PubMed ID: 7395875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.